FUT4 and myeloid sarcoma: Given the profound alterations in the myeloid cell compartment in RRMSi patients (Figures 3–5), we asked whether the levels of circulating Lin− SSChi granulocytes, CD15+ neutrophils, and monocyte subsets can be used as diagnostic markers to discriminate between MS course types.